Ligand · O16
O16 · 3-(1,3-benzothiazol-2-yl)-2-(1,4-dioxo-1,2,3,4-tetrahydrophthalazin-6-yl)-5-[(E)-2-phenylvinyl]-3H-tetraazol-2-ium
O16, 3-(1,3-benzothiazol-2-yl)-2-(1,4-dioxo-1,2,3,4-tetrahydrophthalazin-6-yl)-5-[(E)-2-phenylvinyl]-3H-tetraazol-2-ium (C24 H16 N7 O2 S +1, 466.5 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every…
- Component
- O16
- Formula
- C24 H16 N7 O2 S +1
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
O16 in 2 structures; the first of them:
- 1V40 · First Inhibitor Complex Structure of Human Hematopoietic Prostaglandin D Synthase · O16 A3201 · binds TYR8, PHE9, MET11, GLY13, ARG14, ASP96, MET99, TRP104 and 4 more
- 1V40 · First inhibitor complex structure of human hematopoietic prostaglandin D synthase · O16 A3201 · binds TYR8, PHE9, MET11, GLY13, ARG14, ASP96, MET99, TRP104 and 4 more
Residues it binds most
MET 8, TYR 8, ALA 8, ARG 8, ASP 8, CYS 8, GLY 8, LEU 8, PHE 8, TRP 8 (residue and the binding sites it lines).
Found with
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.